Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3for osteoporosis in women
β Scribed by Staffan A. V. Eriksson; J. Urban Lindgren
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 276 KB
- Volume
- 53
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Retinoids, cytokines as well as 1,25βdihydroxyvitamin D~3~ [1,25(OH)~2~D~3~] and analogs possess properties known to contribute potentially to cancer chemopreventive and chemotherapeutic effects. They induce cell differentiation, inhibit cell prolifeation, suppress expression of viral o
la,25-Dihydroxyvitarnin D3 (10-l2 M to M) caused a dose dependent increase in PKC activity in the solubilized membrane fractions of cultured human keratinocytes and in the cytosolic fractions of cultured human fibroblasts. Maximum activity was induced by 1 a,25-dihydroxyvitamin D3 at 24 h. Sphingosi